Bio Pharma Dive
AUGUST 5, 2020
Early preorders for small quantities of Moderna's shot set a price per dose of $32 to $37, although the biotech plans to charge less in larger agreements.
Camargo
AUGUST 5, 2020
Whether you plan to out-license or commercialize your product, getting the label right matters. When. The post Developing Drug Products with the Label’s Commercial Value in Mind appeared first on Camargo.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
AUGUST 5, 2020
The agreement, which would supply the U.S. with 100 million doses of J&J's experimental shot, is the latest in a string of deals the country has reached with vaccine developers.
World of DTC Marketing
AUGUST 5, 2020
QUICK READ: There are a lot of patient-centered, hard-working people within the pharma industry. The problem is that there are way too many senior managers whose only goal is to remain relevant within the organization even if it means patients suffer. Trade magazine awards don’t mean anything if one company makes a bad decision that stains our industry.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
XTalks
AUGUST 5, 2020
Single cell sequencing has revolutionized the study of biological tissues and systems at the cellular and molecular level. Recent advances in the technology have allowed for the interrogation of distinct subsets of cell populations within tissues, and associated molecular markers that may function as important disease drivers. The use of single cell sequencing in profiling bulk, heterogeneous tissues at the single cell level can help in the identification of dominant, unique and rare cell subtyp
pharmaphorum
AUGUST 5, 2020
The UK government has asked pharma companies to build a six-week stockpile of drugs and find alternative shipping routes to the congested Dover-Calais crossing as the country heads for Brexit at the end of the year. In a letter , Steve Oldfield, chief commercial officer at the Department of Health and Social Care, said the government is focused on preventing potential disruption to any categories of medical supplies.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
pharmaphorum
AUGUST 5, 2020
The UK digital mental health support platform Kooth has joined with five of the UK’s well known Instagram influencers to launch a campaign to help students deal with the pressures of exam results season. The campaign encourages the hundreds of thousands of students waiting to receive their exam results, to stay mentally strong and know they have access to support, if needed.
XTalks
AUGUST 5, 2020
It’s difficult and perhaps not even fair to judge how fast food players have fared with a patchwork quilt of shutdowns and restrictions during COVID-19. But QSR Magazine came out with its Top-50 rankings for quick service restaurants with fast service in 2020. Due to the global pandemic and a few other factors, there’s been some movement on the list.
Olympian Clinical Research
AUGUST 5, 2020
Hidradenitis Suppurativa , also known as acne inversa, is a skin condition that causes small painful bumps or boils to form near the hair roots under the skin in areas like the armpits, groin, breasts, or buttocks. It’s a fairly common condition, with around 200,000 cases diagnosed each year and can lead to infection and other complications. . For patients that suffer from Hidradenitis Suppurativa, the condition can have a devastating impact on self-confidence and quality of life.
NY Times
AUGUST 5, 2020
How much freedom should front-line clinicians have in treating Covid-19 patients with unproven drugs? The question opened up a civil war in some hospitals.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharma Times
AUGUST 5, 2020
AZ will pay $17m in early milestone payments for the UK biotech’s fibrotic asset
BioSpace
AUGUST 5, 2020
With a $30 million investment, Versant Ventures launches Matterhorn Biosciences AG, a company developing T cell receptor therapies based on the recent discovery of MR1-restricted T (MRIT) cells that recognize and kill a wide range of tumors of various tissue origins.
Outsourcing Pharma
AUGUST 5, 2020
The bipartisan bill calls for an assessment of the countryâs pharma supply chain, including potential vulnerabilities and impact of foreign manufacturing.
BioSpace
AUGUST 5, 2020
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 5, 2020.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Pharma Times
AUGUST 5, 2020
Roche, AstraZeneca, Novo Nordisk and Sanofi all climbed index rankings
BioSpace
AUGUST 5, 2020
Researchers are developing simpler COVID-19 diagnostic tests for use outside of labs in an effort to make mass testing available, fast and inexpensive.
Scienmag
AUGUST 5, 2020
Credit: Mary Ann Liebert, Inc., publishers New Rochelle, NY, August 5, 2020–Individuals playing a virtual reality (VR)-based game showed a higher navigational efficiency and less disorientation than those playing a non-VR immersive desktop version, according to a study in the peer-reviewed journal Cyberpsychology, Behavior, and Social Networking.
BioSpace
AUGUST 5, 2020
Several polls have suggested that as much as half of the U.S. population is unlikely to get the vaccine for a variety of reasons, including not feeling it is safe.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
XTalks
AUGUST 5, 2020
Findings from several research studies published last week, including one published in the journal JAMA and three presented at the Alzheimer’s Association International Conference (AAIC) held virtually on July 29, have shown that a blood test could detect early stage Alzheimer’s disease. Xtalks spoke with Dr. Suzanne Schindler, a neurologist at the Washington University School of Medicine in St.
BioSpace
AUGUST 5, 2020
According to a warning from federal officials last week, dozens of drug companies, universities and medical device manufacturers owe more than a decade’s worth of data from clinical trials.
Intouch Solutions
AUGUST 5, 2020
Major national pharmacy chains have announced new options for patients who would like affordable, one-stop, comprehensive healthcare outside of the traditional care setting, as well as new opportunities for PCPs. Three Intouch market access experts offer considerations and opportunities for pharma marketers to navigate this growing retail healthcare delivery trend.
BioSpace
AUGUST 5, 2020
GentiBio focuses on engineered regulatory T-cells (EngTregs) to treat autoimmune, alloimmune, autoinflammatory and allergic diseases.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
AUGUST 5, 2020
Credit: Prabin Bajgain Compared to annual crops, perennial crops provide sustainable environmental benefits such as reduced soil and water erosion, reduced soil nitrate leaching, and increased carbon sequestration. Inclusion of sustainable cropping systems into mainstream agriculture has been a challenge given the lack of food-grade perennial grain cultivars.
BioSpace
AUGUST 5, 2020
The company announced data from Phase I of its Phase I/II placebo-controlled trial of its vaccine with and without Matrix-M adjuvant.
Scienmag
AUGUST 5, 2020
Research will explore ‘orphan’ receptors as potential drug targets for mental health disorders Credit: Sanford Burnham Prebys Medical Discovery Institute LA JOLLA, CALIF. – August 6, 2020 – Sanford Burnham Prebys Medical Discovery Institute has been awarded a $4.5 million grant from the National Institutes of Health (NIH) to identify new therapies for mental health […].
Pharma Times
AUGUST 5, 2020
Company expect to file regulatory submissions in 2021
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
AUGUST 5, 2020
Credit: Chris Stoker/Adranos WEST LAFAYETTE, Ind. – Adranos Inc., a Purdue University-affiliated company that has developed a high-performance solid rocket fuel called ALITEC for missile and space launch systems, has obtained more than $1.1 million in contracts collectively from the U.S. Army’s Aviation and Missile Center and the OUSD (R&E)’s Rapid Reaction Technology Office.
pharmaphorum
AUGUST 5, 2020
The perception of pharma and medical product companies has surged forward since the start of the COVID-19 pandemic, but they still lie mostly outside the top-rated firms in the FutureBrand Index. Roche, AstraZeneca, Novo Nordisk, and Sanofi all shot up the rankings in the first edition of the report since the start of the coronavirus crisis, but the big loser was Gilead Sciences, falling 71 places to 74 in the list since the last edition in 2018.
Scienmag
AUGUST 5, 2020
As a global center for petrochemical manufacturing, Houston, Texas, experiences some of the worst air quality in the country, according to the U.S. Environmental Protection Agency. Evidence suggests that air pollution disproportionately affects low-income, non-white and Hispanic residents, but it’s difficult to directly observe differences in pollutants between neighborhoods.
pharmaphorum
AUGUST 5, 2020
The current level of test and trace in the UK is inadequate to prevent a sharp increase in coronavirus infections when schools reopen in September and there is further relaxation of social distancing rules, according to scientists. A second wave of COVID-19 could be avoided if enough people are tested and traced, according to the team from University College London and the London School of Hygiene & Tropical Medicine.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
334 
Let's personalize your content